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Abstract
The activity of Cdc2 (CDK1) kinase, which coordinates cell cycle progression and DNA
break repair, is blocked upon its phosphorylation at tyrosine 15 (Y15) by Wee1 kinase in the
presence of DNA damage. How Cdc2 can support DNA repair whilst being inactivated by
the DNA damage checkpoint remains to be explained. Human CDK1 is phosphorylated by
Myt1 kinase at threonine 14 (T14) close to its ATP binding site before being modified at thre-
onine 161 (T167Sp) in its T-loop by the CDK-activating kinase (CAK). While modification of
T161 promotes association with the cyclin partner, phosphorylation of T14 inhibits the
CDK1-cyclin complex. This inhibition is further enforced by the modification of Y15 byWee1
in the presence of DNA lesions. In S.pombe, the dominant inhibition of Cdc2 is provided by
the phosphorylation of Y15 and only a small amount of Cdc2 is modified at T14 when cells
are in S phase. Unlike human cells, both inhibitory modifications are executed by Wee1.
Using the novel IEFPT technology, which combines isoelectric focusing (IEF) with Phos-tag
SDS electrophoresis (PT), we report here that S.pombe Cdc2 kinase exists in seven forms.
While five forms are phosphorylated, two species are not. Four phospho-forms associate
with cyclin B (Cdc13) of which only two are modified at Y15 byWee1. Interestingly, only one
Y15-modified species carries also the T14 modification. The fifth phospho-form has a low
affinity for cyclin B and is neither Y15 nor T14 modified. The two unphosphorylated forms
may contribute directly to the DNA damage response as only they associate with the DNA
damage checkpoint kinase Chk1. Interestingly, cyclin B is also present in the unphosphory-
lated pool. We also show that the G146D mutation in Cdc2.1w, which renders Cdc2 insensi-
tive to Wee1 inhibition, is aberrantly modified in a Wee1-dependent manner. In conclusion,
our work adds support to the idea that two distinct Cdc2 pools regulate cell cycle progres-
sion and the response to DNA damage.
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Introduction
Since its discovery more than 30 years ago, it remained a mystery how a single point mutation
(G146D, Fig 1A and 1C) in S.pombe Cdc2 (CDK1) can override the cell cycle control by Wee1
kinase [1, 2, 3]. Wee1 phosphorylates the highly conserved tyrosine-15 (Y15) residue at the
entrance to the ATP binding site to keep the CDC2-cyclin B complex in its low activity state
until cells are ready to enter mitosis [4, 5]. In S.pombe, Y15 is also modified by Mik1 kinase
when cells progress through S phase [6, 7]. Association of Cdc2 with its cyclin partner is stabi-
lised by phosphorylation of T167 in its activation loop (T loop) (T161 in human CDK1;
Fig 1B) by the CDK-Activating-Kinase (CAK) Cdc7Hs (Msc6Sp, Cak1Sc) [8, 9, 10]. Fission yeast
cells are unusual as they express two CAK enzymes, with Msc6 being redundant with Csk1
[11]. As modification of T161Hs (T167Sp) activates the human CDK1Cdc2-cyclin B complex,
this phosphorylation is tightly coupled with the inhibitory modification of T14 [12]. Human
T14 becomes phosphorylated by Myt1 kinase at the endoplasmic reticulum and Golgi system
before the CDK1-cyclin B complex is modified at T161 in the nucleus by the constitutively
active CAK [12, 13]. T14 modification levels are much lower in fission yeast compared to
Fig 1. Cdc2 exists in three forms with distinct phosphorylation levels. (A) Phosphorylation of S.pombe
Cdc2 at threonine-14 (T14), tyrosine-15 (Y15) and threonine-167 (T167). Cdc2.1w is insensitive to inhibition
byWee1 kinase, whereas Cdc2.3w does not require activation by Cdc25 phosphatase. (B+C) Model of S.
pombeCdc2. The model was produced with the Swiss Model tool (template: PDB ID: 4EOM; identity:
66.78%; range: 1-296aa; coverage: 97%). The positions of T14, Y15, C67Y (cdc2.3w), G146D (cdc2.1w)
and T167 are shown. The ATP ligand and the magnesium ion (yellow) are included. (D) Separation of total
protein extracts of the indicated strains on a normal 10% SDS page and a 10% Phos-tag SDS page. The
Cdc2 bands H, M and U are indicated. (E) IEF of total protein extracts of the indicated strains on a linear pH
gradient (pH3-10).
doi:10.1371/journal.pone.0130748.g001
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mammalian cells and accumulate during S phase in a Wee1-dependent manner [14]. In con-
trast to human cells, yeast cells possess only one main CDK, Cdc2Sp or Cdc28Sc, and in fission
yeast an engineered monomolecular Cdc2-cyclin B kinase complex can drive the orderly pro-
gression through the cell cycle in the absence of the remaining cyclins [15]. Mitosis is triggered
by the abrupt activation of the Cdc2-cyclin B complex upon its dephosphorylation at T14 and
Y15 by Cdc25 phosphatase [16, 17]. In human and yeast, activation of the DNA damage check-
point delays cell cycle progression as Y15 phosphorylation accumulates. This accumulation is
caused by the simultaneous removal of Cdc25 from the nucleus and the up-regulation of Wee1
kinase [18, 19, 20, 21].
This model of Cdc2 regulation brings up a second very intriguing question. How can Cdc2
regulate the response to DNA damage, when the Cdc2-cyclin B complex is kept in an inactive
state by Y15 phosphorylation? Cdc2 promotes the repair of broken chromosomes by non-
homologous end joining (NHEJ) in G1 and by homologous recombination (HR) in G2 by reg-
ulating DNA end resection [22, 23, 24]. Interestingly, this regulation is compromised in the
cdc2.1wmutant. The premature rise in Cdc2 activity due to the G146D mutation promotes
NHEJ in G2 at the expense of HR by locking the DNA damage checkpoint protein Crb2
(53BP1Hs) in its G1 mode [25]. This repair defect may explain why cdc2.1w cells are only sensi-
tive to DNA replication fork breakage caused by the topoisomerase 1 inhibitor camptothecin
(CPT), whereas Δwee1 cells possess a much broader sensitivity profile [25, 26].
To further understand how Cdc2 exerts its diverse functions, we revisited an important
observation which was made more than 25 years ago by Potashkin and Beach (1988) [27].
They reported seven Cdc2 species of differing charge in S.pombe. Intriguingly, only five species
(species: C, D, E, F, G) could be labeled with radioactive orthophosphate while two species
(species: A, B) remained unphosphorylated. To assign these species to the known phosphoryla-
tion sites T14, Y15 and T167, and to find out which species are the target of the DNA damage
checkpoint, we utilized the novel combination of isoelectric focusing (IEF) with Phos-tag SDS
electrophoresis (IEFPT) [28]. In the first dimension, IEF separates Cdc2 proteins by their dif-
ferent isoelectric points (IPs). As the IP is equivalent to the overall charge of the protein, it is
not only influenced by phosphorylation but also by sulfation of tyrosine, acetylation or methyl-
ation of lysine, deamidation of asparagine and glutamine, or carboxylation of glutamate [29].
In the second dimension, Cdc2 species are separated by their degree of phosphorylation as the
Phos-tag acrylamide slows down the movement of phosphorylated protein by the formation of
a reversible manganese-phosphate-Phos-tag complex [30]. Consistent with the previous report
[27], the IEFPT technology revealed seven dominant Cdc2 forms in logarithmically growing
wild type cells. Amongst these seven forms, four species are highly phosphorylated (H), one
species contains a medium level of phosphorylation (M) and two species are unphosphorylated
(U). While all four H-forms bind to cyclin B (Cdc13Sp), which implies that they carry the T167
phosphorylation, only two H-forms (He + Hf) are the target of the DNA damage checkpoint as
the Y15 modification is restricted to them. The most extensively phosphorylated form, Hf, may
also be modified at T14 as its abundance strongly declines in the cdc2.T14Amutant. The modi-
fication status of the M-form is not yet known, but it is noteworthy that it doesn`t have a high
affinity for cyclin B. Intriguingly, both unphosphorylted forms (Ua + Ub) associate with the
DNA damage checkpoint kinase Chk1 independently of DNA damage. Applying this IEFPT
analysis to cdc2.1w, Δwee1 and cdc2.1w Δwee1mutants, we found that Cdc2.1w kinase is aber-
rantly modified in a manner dependent on Wee1. Taken together, our results entertain a
model such that unphosphorylated Cdc2 contributes to the DNA damage response via Chk1
while the Y15 modified phospho-forms regulate cell cycle progression.
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Materials and Methods
Strains
wild type (h- ade6-704 leu1-32 ura4-D18), cdc2.1w (h- leu1-32 ura4-D18 cdc2.1w), cdc13-245
(h- leu1-32 ura4-D18 ade6-704, cdc13-245), cdc13-245 cdc2.1w (h- leu1-32 ura4-D18 ade6-704
cdc13-245 cdc2.1w), Δwee1 (h- wee1::ura4+ ade6-704 leu1-32 ura4-D18), cdc2.1w Δwee1
(cdc2.1w wee1::ura4+ ade6-704 leu1-32 ura4-D18), Δmik1 (mik1::ura4+ ade6-704 leu1-32
ura4-D18), cdc2.1w Δmik1 (cdc2.1w mik1::ura4+ ade6-704 leu1-32 ura4-D18), cdc2.T14A
(h- cdc2.L7::cdc2.T14A ade6-M216 his3.D1 leu1.32 ura4.D18), chk1-HA[31], cdc13-HA
(h- cdc13-HA-ura4+ leu1.32 ura4-D18).
Antibodies and Materials
Anti-Cdc2 antibody (ABCAM ab5467); anti-Cdc2-Y15P antibody (Cell Signalling 9111S),
HA-probe antibody (F-7) (Santa Cruz, sc-7392), acetylated-lysine antibody (Cell Signaling,
9814S), Phos-tag acrylamide (AAL-107 Wako Ldt), IEF Dry Strips pH3-10 linear (Biorad,
163–2000), anti-HA magnetic beads (Pierce, 88836), protein A agarose (Pierce, IP06).
Biochemical Techniques
Isoelectric focusing: 5x108 cells were harvested, washed with 1xPBS and resuspended in 300μl
IEF buffer (7M urea, 2M thiourea, 4% CHAPS, 50mM DTT, 0.2% carrier ampholytes [pH3-10
linear], 0.0002% bromophenol blue) with six microspoons of zirconia-silica beads (Thistle Sci-
entific) in a 2ml mircotube. Extracts were prepared on a cell disruptor (Scientific Industries).
Insoluble material was removed from the supernatant at 12,000rpm for 5min. 10μl of superna-
tant was added to 115μl of IEF buffer and loaded onto a Ready Dry strip (linear pH3-10). Strips
were rehydrated for 12 hours at 50V on a Biorad PROTEAN IEF cell and focused using the
rapid ΔVmethod over 10,000Vh. Strips were sequentially incubated for 10min in 2.0ml of
equilibration buffer I (6M urea 0.375M Tris-HCl (pH8.8), 2% SDS, 20% glycerol, 2% DTT)
and 2.0ml equilibration buffer II (6M urea, 0.375M Tris-HCl (pH8.8), 2% SDS, 20% Glycerol,
2.5% Iodoacetamide) prior to electrophoresis on a 10% SDS page. Phos-tag SDS acrylamide
gels (9%) were prepared according the manufacturer’s instructions with 75μM Phos-tag. Man-
ganese ions were removed prior to the transfer onto nitrocellulose membranes by incubating
the gel three-times for 10min in transfer buffer with 20mM EDTA pH8.0. Native Electrophore-
sis: [32]; Total Protein Extracts: [33], Soluble Protein Extracts: [34].
Immunoprecipitation: 5x108 cells were harvested, washed with 1xPBS and resuspended in
300μl lysis buffer (20mMHEPES pH7.2, 200mM potassium acetate, 5mM β-glycerolpho-
sphate, 1mMNaF, 0.1% Nonidet P-40, 10% glycerol, 1mM EDTA pH 8.0, 2mM activated
sodium-orthovanadate, 1:100 Protease Inhibitor Cocktail IV (Melford P2402)). Soluble
extracts were prepared as described above but at 4°C. Precipitation was performed overnight
with 100μl protein extract, 900μl lysis buffer, 4μl anti-Cdc2 antibody and 30μl protein A aga-
rose, or 20μl anti-HA magnetic beads. The beads were washed five times with 1ml lysis buffer
without inhibitors and resuspended in 100μl IEF buffer without DTT. 20μl of the eluted mate-
rial was added to 100μl IEF buffer and loaded on a IEF strip.
Phosphatase treatment: Cdc2 protein was precipitated with the anti-Cdc2 antibody and the
sample was washed three times with lysis buffer and twice with water. Half of the bead sample
was incubated in 1x phosphatase buffer only, and the second half in the buffer plus the phos-
phatase enzyme (5μl Calf Intestinal Alkaline Phosphatase (New England Biolabs, M0290S) or
5μl lambda protein phosphatase (NEB P0753S)). The bead samples were incubated for 60min
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at 37°C (CIP) or at 30°C (lambda). The reactions were stopped by the addition of 100μl IEF
buffer (without DTT). 20μl of the bead samples were subjected to IEF.
Results
Cdc2 exists in three pools with different phosphorylation levels
Phospho-amino acid analysis conducted by Potashkin and Beach (1988) [27], and by Gould
and Nurse (1989) [5] detected high levels of phosphorylated threonine and tyrosine, but only
very little phospho-serine when Cdc2 was affinity purified from logarithmically growing S.
pombe cells. Isoelectric focusing (IEF) of radioactively labeled, affinity-purified Cdc2 protein
revealed six dominant forms from which only four are phosphorylated [27]. Later work identi-
fied T14, Y15 and T167 as the only three phosphorylation sites in Cdc2Sp modified by Wee1
(T14, Y15) and the two CAK kinases Msc6 and Csk1 (T167), respectively (Fig 1A and 1B)
[5, 14, 10, 11]. How these three phosphorylation events map onto the four phospho-species
and what the function of the two unphosphorylated forms is remained so far unexplained.
Informed by our recent finding that the mutant kinase Cdc2.1w (G146D; Fig 1C) imprints a
G1-like DNA repair mode onto G2 cells [25], we wanted to find out whether the phosphoryla-
tion pattern of Cdc2.1w differs from the wild type kinase. We addressed this question by a
combination of IEF and Phos-tag SDS electrophoresis (IEFPT). The Phos-tag compound
forms reversible metal-phosphate complexes thereby slowing down the migration of phosphor-
ylated proteins [30]. The Phos-tag reagent has a very high affinity to phosphate (Kd = 25nM)
and a more than 5000 times lower affinity for the related sulfate ion. We started our analysis by
separating total protein extracts prepared from logarithmically growing wild type and cdc2.1w
cells on a normal 10% SDS page and on a 10% SDS page containing 75μM Phos-tag. Cdc2 was
visualized with an anti-Cdc2 antibody after transfer onto nitrocellulose membrane. While only
one 35kDa band (Cdc2: 297aa, 34.36 kDa, IP: 7.68) was detect after separation on a normal
10% SDS page, electrophoresis in the presence of the Phos-tag reagent revealed three bands
(H, M, U) (Fig 1D). The two upper bands (H+M) migrated more slowly with an apparent
molecular weight of 55kDa and 50kDa, while the third band (U) possessed the expected size of
35kDa. Given that Cdc2 is modified at three sites (T14+Y15+T167), we speculated that the
highly modified H band represents fully phosphorylated Cdc2, whereas band M contains the
partially modified kinase and band U the unmodified protein. Interestingly, the Cdc2.1w
kinase produced a similar pattern, but the mobility of bands H and M was reduced compared
to the wild type protein (Fig 1D).
Since this reduction in mobility suggests additional phosphorylation events specific to
Cdc2.1w, we subjected total protein extracts to IEF on a linear pH gradient ranging from 3 to
10 prior to electrophoresis on a normal 10% SDS page. This revealed six Cdc2 forms with dis-
crete isoelectric points (IP) in wild type extracts (Fig 1E, panel 1). Since Potashkin and Beach
reported a similar IEF pattern [27], we labeled the six forms A to F as in their original publica-
tion with F being the most negative (acidic) form and A the least negative (alkaline) form
(Fig 1E). The presence of one additional negative charge at position 146 in Cdc2.1w shifted all
forms closer to the acidic anode as reported previously by Potashkin and Beach (Fig 1E, panel
2). Given the reduced movement of the Cdc2.1w bands H and M in the presence of the Phos-
tag reagent (Fig 1D), aberrant phosphorylation may contribute to this shift in addition to the
G146D mutation. Interestingly, loss of Wee1 kinase (Δwee1) reduced the intensity of the more
negative forms (B to F) while strongly increasing the amount of the least negative form A
(Fig 1E, panel 3). A decrease in Cdc2 phosphorylation in the absence of Wee1 is expected as
only Mik1 remains to modify T14 and Y15 [6]. We were however surprised by the IEF pattern
of the Δwee1 cdc2.1w extract. The most negative form F was no longer detectable and a strong
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signal at the position of the least negative A form re-appeared (Fig 1E, panel 4). Since this A
form has lost its acidic shift, it is possible that Cdc2.1w (G146D) gains a new post-translational
modification in a wee1 deletion strain which neutralizes the negative charge of D146. Since the
intensity of the forms B, C, D and E remained very high in the Δwee1 cdc2.1w strain, loss of
Wee1 may allow another kinase to modify Cdc2.1w. The strongest candidate is Mik1 kinase as
it shares an overlapping substrate specificity with Wee1 and because a Δwee1Δmik1 double
mutant dies from mitotic lethality [6].
Wee1 kinase contributes to the aberrant post-translational modification
of Cdc2.1w
To correlate the IEF forms A-F with the experiments conducted by Potashkin and Beach, we
combined IEF with Phos-tag SDS electrophoresis (IEFPT) as this should confirm the phos-
phorylation status of these forms (Fig 2A). As expected, the four negative forms C to F
migrated more slowly at the height of the H band, whereas the two least negative species (A+B)
migrated faster at the level of the unmodified U band (Fig 2B). While these observations are
consistent with the previous report [27], we observed one additional spot at the medium phos-
phorylated M level. This led us to conclude that spots A and B represent the two unphosphory-
lated Cdc2 species and forms C to F the four phosphorylated forms described by Potashkin
and Beach. Since the A and B species have distinct isoelectric values, but are not phosphory-
lated, other post-translational modifications must contribute to their charge difference. For
example, S.cerevisiae Cdc28Cdc2 is acetylated at lysine-40 (K33 in human and S.pombe Cdc2)
which removes one positive charge and is crucial for its function [35]. We probed affinity-
purified Cdc2 samples with an antibody that detects lysine residues acetylated at their ε-amino
group, but failed to detect a positive signal (not shown). This negative result could however be
due to the limited specificity of this antibody.
The IEFPT analysis of a cdc2.1w extract produced the wild type pattern with one important
difference. The forms A and B displayed a significant acidic shift towards the anode which indi-
cates a more negative charge (Fig 2B, panel 2). To test whether this shift is dependent on a
mutation in cyclin B (Cdc13) or on Wee1 kinase, we repeated the experiment with a cdc2.1w
cdc13-245 double mutant, which carries a temperature-sensitive allele of cyclin B [22], and a
cdc2.1w Δwee1 strain. The mutation in cyclin B had a limited impact on the IEFPT pattern at
the semi-permissive temperature of 30°C as only the intensity of spots D and F was reduced.
Consistent with the earlier IEF experiment, loss of Wee1 resulted in the re-appearance of an
unphosphorylated Cdc2 form lacking the acidic shift, and we observed one additional, very
negative spot in the H range (Fig 2B, bottom panel). We also run extracts from these strains on
a normal 9% SDS page with Phos-tag. While neither the mutation in cyclin B (Fig 2C) nor loss
of Mik1 kinase (Fig 2D) affected the mobility of the phosphorylated Cdc2.1w bands M and H,
inactivation of Wee1 resulted in the appearance of an additional band with a reduced phos-
phorylation level (Fig 2E). Taken together, these observations suggest that Wee1 contributes to
the aberrant phosphorylation pattern of Cdc2.1w as detected by Phos-tag electrophoresis and
protects the mutated kinase from a modification which can neutralize its negative charge at
D146 as indicated by the accumulation of unphosphorylated protein in the A-B sector of the
IEFPT gel.
Only two forms of Cdc2 are tyrosine-15 phosphorylated
The G146D mutation in a loop behind the ATP binding site (Fig 1C) renders cdc2.1w cells spe-
cifically sensitive to the topoisomerase 1 poison camptothecin (CPT) (Fig 3A) [25]. To test
whether CPT treatment affects the IEFPT pattern, we grew wild type and cdc2.1w cells for 4
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hours in rich medium without the drug or with 40μMCPT. DNA replication fork damage by
CPT induced an increase in the intensity of the forms E and F in wild type extracts suggesting
that both species are Y15 phosphorylated. A similar change was evident in the CPT-treated
cdc2.1w extracts (Fig 3B). We also treated wild type cells with 12mM hydroxyurea (HU)
(which only stalls replication forks) or 40 μMCPT for 4 hours to test which of the three Phos-
tag bands reacts with the anti-Y15P antibody. While untreated cells contained only a low
amount of this modification, Y15 phosphorylation accumulated during the incubation with
both drugs only in the H band (Fig 3C).
Fig 2. Wee1 kinase contributes to the aberrant modification of Cdc2.1w. (A) IEFPT analysis: IEF strips
were placed on top of a 10% Phos-tag SDS page. The IEF strip separates Cdc2 by its isoelectric values and
the Phos-tag SDS page by its degree of phosphorylation. (B) IEFPT analysis of total extracts prepared from
the indicated strains. The mobility of the Cdc2 bands H, M and U is indicated. The top panel shows an
example of the normal IEF pattern of wild type cells. The two wild type and cdc2.1w experiments were
conducted independently. The arrows indicate the acidic shift of forms A and B in the cdc2.1wmutant, its
reversal in the cdc2.1w Δwee1 strain, and the additional, highly phosphorylated species in the H range in the
cdc2.1w Δwee1 strain. (C-E) Phos-tag analysis of total protein extracts prepared from the indicated strains.
doi:10.1371/journal.pone.0130748.g002
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To confirm whether the phospho-forms E and F in the H region become Y15 modified, we
immunoprecipitated Cdc2 from wild type extracts treated with 40μMCPT for 4 hours and
probed the affinity purified Cdc2 protein with the anti-Cdc2 and the anti-Y15P antibody.
While the anti-Cdc2 antibody detected all four phospho-forms (C-F), the anti-Y15P antibody
identified only the two most negative species E and F (Fig 3D). This important finding reveals
that only two of the seven Cdc2 species (He + Hf) are the target of the DNA damage check-
point and involved in delaying mitosis in the presence of DNA damage. We confirmed this
conclusion by treating the immunoprecipitated wild type Cdc2 protein after CPT incubation
Fig 3. Only Cdc2-He and Cdc2-Hf are phosphorylated at tyrosine 15. (A) Serial dilutions (10-fold; starting with 107 cells/ml) of the listed strains were
spotted onto YEA plates containing the indicated drugs. The plates were incubated at 30°C for 3 days. One YEA plate was incubated at 37°C. (B) IEFPT
analysis of wild type and cdc2.1w cells grown in rich medium with 40μM camptothecin (CPT) or without the drug. The arrows indicate the increase in the
abundance of the Cdc2 forms He and Hf. (C) Phos-tag analysis of total protein extracts prepared from wild type cells grown in rich medium with 12mMHU
(hydroxyurea causes DNA replication arrest), with 40μMCPT (camptothecin causes DNA replication fork damage) or no drug. The total protein extracts were
probed with the anti-Cdc2 antibody (left panel) or the anti-Cdc2-Y15 phospho-antibody (right panel). (D) Cdc2 was immunoprecipitated with an anti-Cdc2
antibody from CPT-treated wild type cells. The enriched kinase was either probed with the anti-Cdc2 antibody (top panel) or the anti-Cdc2-Y15 phospho-
antibody (bottom panel). Only the H range is shown. (E) Cdc2 was immunoprecipitated with an anti-Cdc2 antibody from CPT-treated wild type cells and
treated with Calf Intestinal Alkaline Phosphatase (CIP), which dephosphorylates tyrosine, with lambda protein phosphatase, which dephosphorylates
tyrosine, threonine and serine, or left untreated. The protein was detected with the anti-Cdc2 antibody. (F) IEFPT analysis of wild type and cdc2.T14A cells
grown in rich medium without a drug.
doi:10.1371/journal.pone.0130748.g003
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with either Calf Intestinal Alkaline Phosphatase (CIP), which preferentially de-phosphorylates
tyrosine residues [36], or with lambda protein phosphatase, which removes phosphates from
tyrosine, serine and threonine. Consistent with the previous result, CIP only removed the spots
E and F, whereas lambda phosphatase removed all four spots (C-F) from the H region (Fig 3E).
These results show that Cdc2-He and Cdc2-Hf are phosphoryated at Y15 in addition to threo-
nine residues, while Cdc2-Hc and Cdc2-Hd are only threonine modified. To distinguish
between T14 and T167 modifications, we compared the IEFPT pattern of untreated wild type
and cdc2.T14A cells. This identified Cdc2-Hf as a strong candidate for carrying the T14 and the
Y15 modifications as the intensity of the F species significantly declined in the cdc2.T14A
mutant. The second Y15 modified form, Cdc2-He, was not affected in the mutant strain (Fig
3F). Unfortunately, a similar experiment with a cdc2.T167Amutant is not possible as this strain
permanently arrests in mitosis [10] and there are no commercial anti-Cdc2-T14P and anti-
Cdc2-T167P antibodies which react with the threonine-phosphorylated S.pombe kinase.
Cyclin B binds to all highly phosphorylated forms
Since we could not test the T167 phosphorylation directly, we decided to immunoprecipitate
cyclin B (Cdc13) from an affinity tagged cdc13-HA strain to find out which Cdc2 forms associ-
ate with it. This assay indicates T167 phosphorylation as this modification is required for the
stable formation of the Cdc2-cyclin B complex [37]. As shown in Fig 4A, Cdc13 associates with
all four phospho-forms (C-F) in the H range. We also noted three additional spots in this area
which we did not observe when Cdc2 was pulled down with the anti-Cdc2 antibody (Figs 3D
and 4A). This implies that not all Cdc2-cyclin B complexes are accessible to the anti-Cdc2 anti-
body. Interestingly, Cdc13 appears to have a very low affinity to the medium phosphorylated
M form as this species was almost absent from the immunopreciptated material (Fig 4A). As
reported previously for the human CDK1CDC2-cyclin B complex [12], Cdc13 associates also
with the unphosphorylated CDK1 kinase. The cellular roles of the unphosphorylated
CDK1-cyclin B complex, which resides in the cytoplasm in human cells, is not yet known.
Unphosphorylated Cdc2 associates with the DNA damage checkpoint
kinase Chk1
We reported recently two Cdc2 protein complexes in S.pombe [25]. A large complex which
may contain Cdc2, cyclin B and the DNA damage checkpoint kinase Chk1, and a smaller com-
plex which may contain only Cdc2 and cyclin B. To find out to which Cdc2 species Chk1
binds, we repeated the immunoprecipitation experiment with a chk1-HA strain [31]. The cells
were treated with either 40μMCPT for 4 hours or left untreated. As shown in Fig 4B, the
chk1-HA pull down material contained only the two unphosphorylated forms Cdc2-Ua and
Cdc2-Ub, but none of the phosphorylated species. Activation of Chk1 by the DNA damage
checkpoint in the presence of CPT was evident from the two phosphorylated forms of the
kinase which migrate closer to the alkaline end of the strip as reported previously [33]. This
unexpected result implies that the unphosphorylated Cdc2 kinase resides in the larger complex
with Chk1. This conclusion is also in line with the association of cyclin B (Cdc13) with the
Cdc2-U forms (Fig 4A). Since Cdc2 is not phosphorylated in this complex it is unlikely that
Cdc2 is the target of Chk1. It is more likely that this complex acts in the response to DNA dam-
age independently of the cell cycle activity of Cdc2 kinase.
Discussion
The phosphorylation of human and S.pombe CDK1 (Cdc2) kinase is restricted to the three
amino acids T14, Y15 and T161Hs (T167Sp) [8, 5, 14, 10, 38]. Earlier work by Potashkin and
Two Distinct Cdc2 Pools
PLOS ONE | DOI:10.1371/journal.pone.0130748 July 1, 2015 9 / 15
Beach revealed four phosphorylated forms and two unphosphorylated species of Cdc2 in loga-
rithmically growing S.pombe cells [27]. How these forms map onto the three phosphorylation
sites and how they contribute to the divers roles of Cdc2 in cell cycle regulation and DNA
repair remained so far unresolved.
Cdc2-Hf may act in S phase while Cdc2-He may regulate the G2-M
transition
Our first key finding is the observation that only two Cdc2 forms are modified at tyrosine 15
(Y15). This identifies Cdc2-He and Cdc2-Hf as the target of Wee1 and Mik1 kinase in cell
cycle regulation (Figs 3 and 4C). Interestingly, both forms differ in the phosphorylation status
of threonine 14 (T14) as only the intensity of the Hf species declines in the cdc2.T14Amutant
(Fig 3F). It is therefore possible that Cdc2-Hf regulates S phase progression as the T14 modifi-
cation peaks during DNA replication in a Wee1-dependent manner [14], whereas Cdc2-Hf
Fig 4. Unphosphorylated Cdc2 associates with Chk1 kinase. (A) Cyclin B (Cdc13) was
immunoprecipitated from untreated and CPT-treated (40μMCPT, 4h) cdc13-HA cells and the precipitated
protein was detected with the anti-Cdc2 antibody. Wild type (cdc13+) cells were included as a negative
control. (B) The DNA damage checkpoint kinase Chk1 was immunoprecipitated from untreated and CPT-
treated (40μMCPT, 4h) chk1-HA cells and the precipitated protein was detected with the anti-Cdc2 antibody
and an anti-HA antibody (Chk1). The arrow indicates the DNA damage-induced phosphorylation of Chk1.
Cdc2-U indicates the unphosphorylated Cdc2 species Ua and Ub. (C) Model. Since all four forms (C-F) in the
H range bind to cyclin B (Cdc13) they are likely to be T167 phosphorylated. Cdc2-Hf may carry phosphate
residues at T14, Y15 and T157, whereas Cdc2-He may be only phosphorylated at Y15 and T167. Cdc2-He
and Cdc2-Hf are both involved in cell cycle regulation. Cdc2-Hc and Cdc2-Hd associate with cyclin B and
may therefore be T167 modified. The unphosphorylated forms Cdc2-Ua and Cdc2-Ub associate with Chk1
and Cyclin B and may act in the response to DNA damage. Cdc2-Mmay be serine phosphorylated.
doi:10.1371/journal.pone.0130748.g004
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coordinates the G2-M transition. The association of both forms with cyclin B (Cdc13) (Fig 4A)
strongly implies that Cdc2-Hf and Cdc2-He are also modified at T167. While phosphorylation
of the T-loop at T167Sp (T161Hs) is not essential for cyclin B binding [8], it significantly stabi-
lises the Cdc2-cyclin B complex [39]. Further support for a model in which Cdc2-Hf regulates
S phase and Cdc2-He the onset of mitosis stems from two previously published findings. Only
the simultaneous mutation of T14 and Y15 to alanine abolishes the link between the comple-
tion of DNA replication and the initiation of mitosis [40], and reactivation of DNA replication
origins after initiation of S phase is prevented by a chromatin bound Cdc2-cyclin B complex
[41]. It seems that the phosphorylation of T14 adopted a different role in yeast compared to
human cells. While the T14 phosphorylation of human CDK1 is tightly coupled to the activat-
ing T161 modification to prevent premature activation of the largely cytoplasmic CDK1-cyclin
B complex during interphase [12], the same modification may earmark the S.pombe Cdc2-cy-
clin B complex for its roles in S phase.
What are the roles of Cdc2-Hc and Cdc2-Hd?
The absence of the Y15 modification strongly indicates a role for Cdc2-Hc and Cdc2-Hd out-
side of cell cycle regulation (Fig 3D). Both forms may only be T167 modified since their inten-
sity hardly changes in the cdc2.T14Amutant (Fig 3F) and because S.pombe Cdc2 is probably
not serine phosphorylated [40]. This conclusion is further supported by their association with
cyclin B (Fig 4A). This raises however an interesting question. If both forms are neither T14
nor Y15 modified, why do cells not enter mitosis prematurely? As this is not the case, Cdc2-Hc
and Cdc2-Hd may be excluded from the nuclear spindle pole body (centrosome in higher
eukaryotic cells) where the cell cycle active forms of Cdc2 reside [42]. Their different isoelectric
points (IP) suggest also the presence of additional modifications which may counterbalance
the activating T167 phosphorylation. Active S.cerevisiae Cdc28Cdc2 is acetylated [35] which
would affect the IP, but we could not detect acetylation at the ε-amino group of lysine residues
by probing affinity-purified Cdc2 with a modification specific antibody (not shown).
Unphosphorylated Cdc2 may play a role in the DNA damage response
Our second key finding is the association of the DNA damage checkpoint kinase Chk1 with the
two unphosphorylated forms Cdc2-Ua and Cdc2-Ub (Fig 4B). S.pombe Chk1 is activated in G1
when cells pass through the start point of S phase [43] and in G2 when DNA damage is
detected [44] to prevent premature mitotis. We recently reported the presence of two distinct
Cdc2 protein complexes in S.pombe [25]. Cdc2-Ua and Cdc2-Ub may be part of the larger
complex (more than 700kDa) which also contained Chk1, whereas Cdc2-He and Cdc2-Hf may
associate in the smaller complex (200-400kDa) from which Chk1 was absent. Cyclin B was
present in both complexes which is in line with its association with Cdc2-Ua and Cdc2-Ub (Fig
4A). Interestingly, a similar unphosphorylated CDK1Cdc2-cyclin B complex is also present in
human cells [12]. Cdc2 is probably not the target of Chk1 in this larger complex as neither
Cdc2-Ua nor Cdc2-Ub are phosphorylated (Fig 3). It is more likely that Chk1 uses the unpho-
sphorylated Cdc2-cyclin B complex to gain access to sites in the cell where it can execute its
functions in cell cycle regulation and DNA repair. One such site could be a licensed DNA repli-
cation origin since Chk1 is activated when cells pass through the start point of S phase.
Whether Chk1 is still modified by Rad3ATR kinase in the Cdc2 complex in the response to
DNA damage is as yet unclear, but possible. Activation of Chk1 by Rad3 at the G1-S transition
is mediated by the chromatin protein Rad4 which also acts at the start of S phase [45], and the
Cdc2-cyclin B complex binds to replication start sites [41]. Taken together, this evidence
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supports a model in which the Cdc2-Chk1 complex regulates early DNA replication events in
the presence of DNA damage.
Is Cdc2.1w aberrantly modified by Wee1 kinase?
As reported previously [27], the presence of the negatively charged aspartate at position 146
(G146D) shifts all Cdc2 forms closer to the positive anode (Fig 1E). Intriguingly, some of this
shift is reversed upon the deletion of wee1 as unphosphorylated Cdc2.1w protein accumulates
in the cdc2.1w Δwee1mutant (Fig 1F). Compared to Δwee1 cells, the impact of Wee1 inactiva-
tion on the abundance of the phosphorylated Cdc2.1w forms C to F is however much reduced
in the cdc2.1w Δwee1 double mutant. These findings led to two interesting conclusions. Firstly,
the negative charge at position 146 in the Cdc2.1w kinase may be neutralized by a novel post-
translational modification in the absence of Wee1 since the acidic shift of the unphosphory-
lated form is no longer detectable (Figs 1E and 2B). Secondly, another kinase may gain access
to Cdc2.1w in cdc2.1w Δwee1 cells as the intensity of the phosphorylated forms remains high
(Fig 1E). This kinase is most likely Mik1 given its overlapping substrate specificity with Wee1
[6]. Mik1 may not be able to fully replace Wee1 in the cdc2.1w Δwee1 strain since a faster
migrating band (i.e. reduced phosphorylation) appears on the Phos-Tag gel (Fig 2E). On bal-
ance, these observations imply that Wee1 shields Cdc2.1w from aberrant modifications by
Mik1 and other enzymes.
Why are Δwee1 cells DNA damage sensitive?
A longstanding mystery is the broad sensitivity profile of Δwee1 cells (Fig 2A) [25] which is
independent of the premature onset of mitosis [26]. So far no direct role of Wee1 in DNA
repair has been discovered which points towards an indirect cause of the DNA damage sensi-
tivity. Our findings provide now an explanation. The accumulation of unphosphorylated Cdc2
in Δwee1 cells (Figs 1E and 2B) may interfere with the DNA damage activities of Cdc2-Ua and
Cdc2-Ub thus contributing to the broad sensitivity spectrum. This idea is in line with the
change of the sensitivity profile of the cdc2.1wmutant upon deletion of wee1. While cdc2.1w
cells are specifically sensitive to CPT, they adopt the broader profile of Δwee1 cells upon the
loss of the kinase (Fig 3A).
What are the roles of the medium phosphorylated Cdc2 form?
In addition to the six main Cdc2 forms, S.pombe cells contain one medium phosphorylated
species (Cdc2-M) (Fig 2B). This form does not react with the anti-Y15 phospho-antibody and
has a very low affinity for cyclin B (Fig 4A). Its abundance is also independent of the cdc2.T14A
mutation (Fig 3F). Taken together, Cdc2-M is probably not phosphorylated at T14, Y15 or
T167. We have however observed that its abundance is lower in the cdc2.1wmutant (Fig 3C)
and that a second species in the M range appears in the absence of Wee1 (Fig 2B). One possibil-
ity is that Cdc2-M is phosphorylated at serine residues. Although very little phospho-serine
has been found in S.pombe [10, 27], chicken CDK1 is modified at serine 277 which is also pres-
ent in S.pombe Cdc2 [46].
Conclusion
The outcomes of this work inform a model in which two distinct Cdc2 pools regulate cell cycle
progression (Cdc2-He + Cdc2-Hf) and the response to DNA damage (Cdc2-Ua + Cdc2-Ub)
(Fig 4C). Further work is however required to understand how Cdc2-Ua and Cdc2-Ub impact
on the DNA damage response, and which post-translational modifications define their distinct
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isoelectric points. It would also be important to identify the cellular activities of Cdc2-Hc and
Cdc2-Hd, which associate with cyclin B but lack the Y15 phosphorylation.
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